Article citationsMore>>

Wallis, C., Mahar, A., Choo, R., Herschorn, S., Kodama, R., Shah, P., Danjoux, C., Narod, S. and Nam, R. (2016) Second Malignancies after Radiotherapy for Prostate Cancer: Systematic Review and Meta-Analysis. BMJ, 352, 851.
https://doi.org/10.1136/bmj.i851

has been cited by the following article:

• TITLE: Influence of Dosimetric Considerations in Evaluating Second Cancer Risks in Prostate Cancer

  AUTHORS: Raghda A. Elgendy, Wahib M. Attia, Ehab M. Attalla, Mostafa A. lnaggar

  KEYWORDS: Prostate Cancer, Second Cancer Risks, 3DCRT, Rotational Arc and IMRT

  JOURNAL NAME: International Journal of Medical Physics, Clinical Engineering and Radiation Oncology, Vol.7 No.2, May 28, 2018

  ABSTRACT: Influence of dosimetric considerations in evaluating second cancer risks in prostate cancer. Material and methods: Fifteen patients in this study suffering from early stage of prostate cancer, each patient underwent three plans: 1) Three-dimensional conformal radiation therapy (3DCRT), 2) Rotation therapy (Arc therapy), and 3) intensity-modulated radiation therapy (IMRT) plan. Estimate secondary metastasis risk models: Excess Relative Risk (ERR) and Excess absolute risk (EAR) based on age of exposure by taking dosimetry data from Dose Volume Histograms (DVHs) to calculate risk models. Result: The second cancer risk models (ERR and EAR) for organs at risk OARs decrease with increasing age of exposure for 3D-CRT, ARC and IMRT and there is no significant difference for ERR and EAR model for developing second cancer risk in 3D-CRT, ARC and IMRT.